P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment

Journal of the American College of Surgeons

Volumn 199, Issue 1, 2004, Pages 69-77

  Papalambros, Efstathios ^a,d   Sigala, Fragiska ^a   Travlou, Anthi ^a   Bastounis, Elias ^a   Mirilas, Petros ^b,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

antibodies against heparin platelet factor 4; arterial thromboembolism; AT; deep vein thrombosis; DVT; heparin induced thrombocytopenia; HIT; HIT antibody; PAOD; peripheral arterial occlusive disease; PF4; platelet factor 4

Indexed keywords

FIBRINOGEN; HEPARIN; PADGEM PROTEIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTERY DISEASE; ARTERY THROMBOSIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; STROKE; THROMBOCYTE; VEIN DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; BLOOD PLATELETS; COHORT STUDIES; FEMALE; FIBRINOGEN; HEPARIN; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET FACTOR 4; PROSPECTIVE STUDIES; THROMBOCYTOPENIA; THROMBOEMBOLISM; VASCULAR DISEASES; VENOUS THROMBOSIS;

EID: 3042561898     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2004.02.027     Document Type: Article

References (29)

1. Stenberg P.E., McEver R.P., Shuman M.A., et al. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 101:1985;880-886
2. Fijnheer R., Frijns C.J., Kortuweg J., et al. The origin of P-selectin as a circulating plasma protein. Thromb Haemost. 77:1997;1081-1085
3. Palabrica T., Lobb R., Furie B.C., et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelet. Nature. 359:1992;848-851
4. Blann A.D., Lip G.Y., Beevers D.G., McCollum C.N. Soluble P-selectin in atherosclerosis a comparison with endothelial cell and platelet markers. Thromb Haemost. 77:1997;1077-1080
5. Blann A.D., Seigneur M., Boisseau M.R., et al. Soluble P-selectin in peripheral vascular disease relationship to the location and extent of atherosclerotic disease and its risk factors. Blood Coagul Fibrinolysis. 7:1996;789-793
6. Blann A.D., Noteboom W.M., Rosendaal F.R. Increased soluble P-selectin levels following deep venous thrombosis cause or effect? Br J Haematol. 108:2000;191-193
7. nd ed. 2001;87-123 Marcel Dekker, New York
8. Vitale M., Tazzari P., Ricci F., et al. Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia. Cytometry. 46:2001;290-295
9. Walenga J.M., Jeske W.P., Messmore H.L. Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Thrombolysis. 10:(Suppl 1):2000;13-20
10. Chong B.H., Grace C.S., Rosenberg M.C. Heparin-induced thrombocytopenia effect of heparin platelet antibody on platelets. Br J Hematol. 49:1981;531-540
11. Hull R.D., Raskob G.E., Rosenbloom D.R., et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med. 152:1992;1589-1595
12. Katayama M., Handa M., Araki Y., et al. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol. 84:1993;702-710
13. Walenga J.M., Jeske W.P., Fasanella A.R., et al. Laboratopy diagnosis of heparin-induced thrombocytopenia. Clin Appl Throm Hemost. 5:(Suppl):1999;21-27
14. Johnston G.I., Bliss G.A., Newman P.J., McEver R.P. Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem. 265:1990;21381-21385
15. Nomura S., Imamura A., Okuno M., et al. Platelet-derived microparticles in patients with arteriosclerosis obliterans enhancement of high shear-induced microparticle generation by cytokines. Thromb Res. 98:2000;257-268
16. Smith A., Quarmby J.W., Collins M., et al. Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis. Thromb Haemost. 82:1999;1593-1599
17. Welbourn C.R., Goldman G., Paterson I.S., et al. Pathophysiology of ischaemia reperfusion injury central role of the neutrophil. Br J Surg. 78:1991;651-655
18. Korthuis R.J., Grisham M.B., Granger D.N. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol. 254:1988;H823-H827
19. Weiser M.R., Gibbs S.A., Valeri C.R., et al. Anti-selectin therapy modifies skeletal muscle ischemia and reperfusion injury. Shock. 5:1996;402-407
20. Jaeschke H. Is anti P-selectin therapy effective in hepatic ischemia-reperfusion injury because it inhibits neutrophil recruitment? Shock. 12:1999;233-234
21. Takada M., Nadeau K.C., Shaw G.D., et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest. 99:1997;2682-2690
22. Kirkpatrick U.J., Mossa M., Blann A.D., McCollum C.N. Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication. Thromb Haemost. 78:1997;1338-1342
23. Johnson-Tidey R.R., McGregor J.L., Taylor P.R., Poston R.N. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Co-expression with intercellular adhesion molecule-1. Am J Pathol. 144:1994;952-961
24. Koksch M., Zeiger F., Wittig K., et al. Haemostatic derangement in advanced peripheral occlusive arterial disease. Int Angiol. 18:1999;256-262
25. Koksch M., Zeiger F., Wittig K., et al. Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease. Eur J Endovasc Surg. 21:2001;147-154
26. rd ed. 1996;3613-3627 Oxford University Press, Oxford
27. Visentin G.P., Ford S.E., Scott J.P., Aster R.H. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest. 93:1994;81-88
28. nd ed. 2001;43-86 Marcel Dekker, New York
29. nd ed. 2001;291-322 Marcel Dekker, New York